Specialty chemicals dealmaking through May 2026 leans on carve-outs and bolt-ons rather than transformative consolidation - BASF Coatings to Carlyle, an amended Honeywell-Johnson Matthey deal, Element Solutions on EFC.
Bruker reported $823.4 million in Q1 2026 revenue, up 2.7% on a 4.5% FX tailwind, but organic growth was negative 4.4% even as BSI bookings rose at a high-single-digit pace for a third straight quarter.
Agilent reported $1.80 billion in first-quarter fiscal 2026 revenue, up 7.0% reported and 4.4% on a core basis, with all three operating segments growing ahead of the May 27 second-quarter release.
Thermo Fisher's Analytical Instruments segment posted $1.72 billion in Q1 2026 revenue, flat year-on-year, with a 2% organic decline tied to softer academic and government demand.
BASF, Dow, and LyondellBasell all reported Q1 2026 results that point to tight capex, footprint rationalisation, and cost programmes - shifting process-analytics demand toward brownfield retrofits, not greenfield builds.
Mettler-Toledo reported $947.1 million in Q1 2026 sales, with management calling out process analytics as small but fast-growing on semiconductor fab build-outs, data-center cooling, and bioprocessing demand.
A scan of vendor press rooms over the March-May 2026 window turns up no new process Raman analyzers from the major suppliers. The visible motion was in adjacent inline analytics and lab-grade Raman.
Updated spec sheets through late 2025 consolidate Endress+Hauser's Raman Rxn-10, -20, -30, -40 and -46 probes under one naming scheme, with the bioprocess Rxn-46 keyed to Sartorius BioPAT Spectro.